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Abstract 
The continuous synthesis of new psychoactive substances on the drug market highlights the 
requirement for a portable, rapid analytical tool with the ability to detect and quantify 
substances at low concentrations, whilst providing sensitive and reproducible results. 
Synthetic cathinone’s are the second largest group of new psychoactive substances and are 
increasingly popular among drug abusers due to their stimulant effects and availability. In 
this study, the electrochemical detection of two synthetic cathinone’s, 3',4'-
methylenedioxy-α-pyrrolidinohexiophenone (MDPHP) and N-ethylpentylone (NEP) were 
studied using screen-printed graphene electrodes. In regards to cyclic voltammetry, the 
linear ranges were found to be 25 – 600 µg mL-1 in acetate buffer (0.1 M, pH 5.5) for NEP 
and 100 – 1000 µg mL-1 in acetate buffer (0.1 M, pH 5.5) for MDPHP.  
Whilst using cyclic voltammetry in regards to the NEP, the linear ranges were found to be 25 
– 600 µg mL-1 in acetate buffer (0.1 M, pH 5.5) using the control NEP and 25 – 500 µg mL-1 in 
acetate buffer (0.1 M, pH 5.5) using the street sample of NEP. The linear range for MDPHP 
was found to be 100 – 1000 µg mL-1 in acetate buffer (0.1 M, pH 5.5) and in spiked diluted 
human urine, for both the control and street sample. The corresponding limit of detection 
were calculated to be 0.046 µg mL-1  , 0.104 µg mL-1 , 0.195 µg mL-1  , 0.130 µg mL-1 and 
0.205 µg mL-1 for the NEP control and street sample in acetate (0.1 M, pH 5.5) , and the 
MDPHP control and street sample in acetate (0.1 M, pH 5.5) and spiked diluted human 
urine, respectively. To increase sensitivity of the method, differential pulse voltammetry 
was utilized and the linear ranges were found to be 25 – 100 µg mL-1 for NEP and 100 – 1000 
µg mL-1 for MDPHP. The corresponding limit of detection were calculated to be 0.130 µg mL-
1 for NEP and 0.348 µg mL-1 for MDPHP. Quantification of MDPHP street samples were also 
recorded and the possible interference of common adulterants was tested using cyclic 
voltammetry. The electrochemical techniques studied show that the detection and 
quantification of synthetic cathinone’s are viable and serves potential to develop as a 








CSEW – Crime Survey for England and Wales 
CV – Cyclic voltammetry  
DPV – Differential pulse voltammetry 
EMCDDA – European Monitoring Centre for Drugs and Drug Addiction 
MDMA - 3,4-Methylenedioxymethamphetamine 
MDPHP - ,  3',4'-methylenedioxy-α-pyrrolidinohexiophenone 
MDPV- 3,4-methylenedioxypyrovalerone 
NEP – N-ethylpentylone 
NPS – New psychoactive substances  
SPE – Screen-printed electrode 
UNODC – United Nations Office on Drugs and Crime 
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1. Introduction 
1.1. Drug abuse 
Around 271 million people across the globe used drugs in the previous year according to the 
2018/19 World Drug Report by The United Nations Office on Drugs and Crime (UNODC)1, 
which is now 30 per cent higher than in 2009. The continual increase in drug misuse globally 
shows an urgent need for international cooperation to develop efficient detection methods, 
prevent supply and work with heath and law enforcements to ensure the correct response 
to drug misuse. The Crime Survey for England and Wales (CSEW)2 2018/19 shows that in the 
United Kingdom itself around 1 in 11 (9.4%) adults aged 16-59 had taken a drug in the last 
year, which equates to around 3.2 million people, out of which around 3.7% had taken a 
Class A drug in the last year. Both figures show an upward trend in comparison to previous 
years and once again highlight an ongoing issue. The drug market has proved a difficult area 
to maintain control over given the diversification of substances available, especially the 
focus put onto the misuse of prescription drugs and the development of new psychoactive 
substances (NPS), also known as synthetic drugs, over the last decade. New psychoactive 
substances are structurally similar to existing illicit drugs and mimic the desired effects, 
however due to the usually higher potency and potential combination of unknown drugs to 
customers, there is a greater risk of fatalities and long-term effects. As new substances are 
constantly being synthesized and sold as alternatives to, or mixed with, controlled 
substances, there is a considerable challenge for prevention and treatment. The main 
factors that have increased popularity for NPS use is the low price and availability with the 
possibility to avoid using legally banned substances. Users believe that these substances are 
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1.1.1. Types of Drugs 
The UNODC defines new psychoactive substances as “substances of abuse, either in a pure 
form or a preparation, that are not controlled by the 1961 Single Convention on Narcotic 
Drugs or the 1971 Convention on Psychotropic Substances, but which may pose a public 
health threat”3. Following this, new psychoactive substances have been categorised into 
seven key types4: hallucinogens, dissociative, opioids, cannabinoids, depressants, 
empathogens and stimulants. The 2019 World Dug Report by the United Nations Office on  
Drugs and Crime (UNODC)5 highlights the increase of stimulant use: after cannabinoids, 
stimulants constitute the second most widely used group of drugs used across the globally, 
accounting for 68-million yearly users within the past year. 
1.1.2. Drug Laws 
There have been international responses to the continuous emergence of new psychoactive 
substances by the World Health Organization (WHO) Expert Committee on Drug 
Dependence (ECDD)6, who carry out in-depth evaluations of reported psychoactive 
substances, in order to determine whether the substances should be placed under 
international control. The European Union also responded by creating the European Union 
Early Warning System (EWS)7 which is operated by the EMCDDA and Europol, which allows 
for monitoring, detection, assessment and response to health and social threats by these 
substances.  Many countries have specific new psychoactive substance related legislation 
including Austria (New Psychoactive Substances Act)8, Ireland (Criminal Justice Psychoactive 
Substances Act 2010)9 and New Zealand (The Psychoactive Substances Act 2013)10.  
The UK Misuse of Drugs Act (1971) was introduced to provide a legislative framework to 
prevent the misuse of controlled drugs by preventing manufacture, supply and possession. 
A complete ban was placed on possessing, importing and exporting controlled drugs unless 
otherwise stated by regulations. Controlled drugs can be divided into three classes: Class A, 
B and C. Examples of drugs and the penalties for each class are stated in table 1.   
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Table 1. Drug class system 
 
As stated above, although the manufacture, supply and possession of controlled drugs is 
prohibited unless permitted by regulations. The Misuse of Drugs Regulations (2001) defines 
the conditions that the supply and possession of controlled drugs is permitted and under 
which professional capacities. Controlled drugs are divided into five Schedules, which 
defines the requirements surrounding the possession, production, supply and prescription 







Class Drug Penalties 
Class A • Heroin 
• Cocaine 
• Ecstasy (MDMA) 
• LSD 
• Methadone 
Possession of drug: 
• Unlimited fine 
• Up to 7 years in prison 
Supply / Production 
• Unlimited fine 
• Up to life in prison 
Class B • Cannabis 
• Ketamine 
• Synthetic cannabinoids 
• Synthetic cathinones 
• Amphetamines 
Possession of drug: 
• Unlimited fine 
• Up to 5 years in prison 
Supply / Production 
• Unlimited fine 
• Up to 14 years in prison 
Class C • Diazepam 
• Piperazines 
• Khat 
• Anabolic steroids 
Possession of drug: 
• Unlimited fine 
• Up to 2 years in prison 
Supply / Production 
• Unlimited fine 
• Up to 14 years in prison 
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Table 2. Schedule system  
Schedule Example of Drug Requirements 
1 
 
• Ecstasy type drugs 
• Hallucinogenics 
• Cannabis 
• Raw opium  
• A Home Office licence is 
required for production, 
supply or possession. 
• Controlled drugs 
supplied by a pharmacy 
must be recorded in a 
controlled drug register.  
2 • Opiates (morphine) 
• Cannabis-based products  
• Cocaine 
• Heroin 
• Possession and supply is 
allowed for pharmacists 
and others stated in the 
2001 legislation  
• Controlled drug register 
is required 
3 • Gabapentin 
• Tramadol 
• Pregabalin 
• Safe custody 
requirements 
• Records in register is not 
required but invoices 
must be kept for 2 years 
4 • Minimal control drugs 
• Midazolam  
• Anabolic steroids  
• No requirements for 
controlled drug register 
records or safe custody  
5 • Preparations of 
particular controlled 
drugs (e.g. morphine) 
• Exempt from controlled 
drug requirements due 
to low strength of drug  
 
Although the legislation put into place was useful and placed a ban over the supply/ 
possession of the controlled drugs, the emergence of psychoactive substances became 
increasingly popular in order to avoid the stated laws, as the substances were similar but 
not the exact controlled drug. Therefore, the UK Psychoactive Substances Act came into 
effect on 26th May 2016 and made it an offence to produce, supply, and offer to supply, 
possess with intent to supply, import or export psychoactive substances with a maximum 
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1.1.3. Cathinones 
Cathinone is a naturally occurring alkaloid found in the leaves of the khat plant (Catha 
edulis) found in North East Africa and the Arabian Peninsula. Peter Forskal first discovered 
the shrub in the eighteenth century and methcathinone was the first synthetic cathinone to 
be synthesized in 192812, followed by mephedrone which was first mentioned in 1929 in the 
Bulletin de la Societe Chimique de France13. Abuse of these substances was not reported till 
the early 21st century, when in 2007 mephedrone was the first synthetic cathinone to be 
detected by European Authorities in 2007 and then in 28 European countries in 2010. 
Synthetic cathinones belong to the class psychostimulants, due to their stimulant nature 
they act on the central nervous system and increase alertness and can cause behavioural 
excitement14. They are often referred to by their street name of “bath salts” and are sold as 
stimulants via internet forums or “headshops”, prior to the new psychoactive substance ban 
in 2016, under names such as “Flakka”, “Ivory Wave”, “Vanilla Sky” and “Cloud Nine”15. 
Reported effects include extreme paranoia, hallucinations, increased energy and 
aggressiveness16.  Synthetic cathinones alongside synthetic cannabinoids makeup the largest 
groups of new psychoactive substances monitored by the EMCDDA and reflects the demand 
for stimulants in Europe.   
1.1.4. N-ethylpentylone  
N-Ethylpentylone (NEP) is a synthetic cathinone synthesized in the 1960’s for 
pharmaceutical use and it first appeared in USA in 2014 and more prominently in Europe in 
2016. The substance is used as an alternative to MDMA (commonly known as “ecstasy” or 
“molly”) and majority of the time drug users are unaware of the contents as the tablets are 
marked with the same logo characteristics as MDMA. Although these tablets appear to be 
similar, NEP is three to four times more potent than MDMA, and leads to extreme negative 
effects including severe insomnia, paranoia, aggressiveness and drug-induced psychosis. Not 
only does it cause longer-lasting negative effects, there have been reports of fatalities due 
to the unexpected high potency of the substance globally, including two fatalities in 
Alabama in 2017 reported by Atherton et al17 and one in Baltimore reported by Ikeji et al18 
in 2018. NEP has been detected in various pills over the past year, especially common in 
festivals in the UK: The Loop reported that yellow “Super Mario” pills were being circulated 
in Cornwall19. 






Figure 1. Structure of N-ethylpentylone  
 
 
1.1.5. MDPHP  
Another synthetic cathinone that has recently appeared on the UK drug market is 3',4'-
methylenedioxy-α-pyrrolidinohexiophenone (MDPHP), shown in figure 2 , which is an analog 
of 3,4-methylenedioxypyrovalerone (MDPV), shown in figure 3, and differs by the addition 
of a single carbon to the alkyl side chain. MDPV was first developed in 1969 by a team at 
Boehringer Ingelheim20 as a possible pharmaceutical drug for chronic fatigue and resurfaced 
as a drug of abuse in the early 21st century, with formal notification to the EMCDDA being 
made in 200821. Similarly MDPHP was first synthesized in 1960 but only recently appeared 
as a recreational drug after MDPV was put under control of the Misuse of Drugs Act (1971) 
in 2010 as a Class B drug. Commonly known as “Monkey-Dust”, the synthetic cathinone 
received widespread media attention and was branded as “Zombie-Dust” or “Cannibal-
Dust” as there are many reports claiming users’ experienced super-human strength and a 
zombie-like attraction to eat human faces. However, there is little evidence to support the 
claims that MDPHP is the reason for these effects, as many reports were proven incorrect 
and baseless. Due to limited history of use, there is difficulty in determining the long-term 
effects MDPHP may have; however, we can gain insight into the short-term effects by 
referring to case studies of use (later discussed) and reports from authorities. Reports of 
MDPHP gained increase in 2018 in the UK, particularly Staffordshire, as Staffordshire Police 
reported 950 calls related to the drug in a three-month time frame22. First-responders from 
the West Midlands Ambulance Service released a statement regarding their experience with 
MDPHP users, explaining that a variety of effects have been seen on individual patients, 
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including paranoia and lack of fear23. It can be concluded that MDPHP displays common 





Figure 2. Structure of MDPHP                                                     Figure 3. Structure of MDPV 
1.2    Existing Detection Methods 
 
The constant synthesis of new substances has highlighted an urgent need to develop 
detection and quantification methods that can also be used by first-responders or law 
enforcements: a number of researchers globally have used a range of analytical techniques 
to detect and characterize synthetic cathinones. 
 
Liquid chromatography-high resolution mass spectrometry (LC-MS) and gas 
chromatography-mass spectrometry (GC-MS) are the most popular choices for the analysis 
of synthetic cathinone’s. In 2019 Błażewicz et al.24 identified and analytically characterized 
analytically characterized seven cathinone derivatives using liquid chromatography-high-
resolution tandem mass spectrometry (LC-ESI-QTOF-MS), gas chromatography with mass 
spectrometry (GC-EI-MS) and nuclear magnetic resonance spectrometry (NMR). The 
detection of and characterization of the following synthetic cathinone’s was reported: N-
propylcathinone, 2,4-dimethylmethcathinone (2,4-DMMC), 2,4-dimethyl-a-
pyrrolidinopropiophenone (2,4-DMPPP), 2,4-dimethylethcathinone (2,4-DMEC), 4-bromo-α-
pyrrolidinopropiophenone (4-Br-PPP), 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-
yl)hexan-1-one (5-BPDi) and 2,4-dimethylisocathinone (4-iso-DMC). The premise of research 
was to focus primarily on using the given techniques to elucidate the synthetic cathinone 
derivatives structures, rather than developing a more sensitive method of detection than 
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previously reported. This research is useful for characterisation of a cathinone but does not 
improve existing methods to detect the cathinone’s successfully. The techniques used in this 
research are all laboratory based so cannot be utilised in-the-field.   
 
In 2015 Hong et al25. conducted a study that proposed a method using gas chromatography-
mass spectrometry (GC-MS) to analyse and quantify the following six synthetic cathinone’s 
in urine samples: mephedrone (4-MMC), methylone (bk-MDMA), butylone, ethylone, 
pentylone and methylenedioxypyrovalerone (MDPV).  The results found that the limit of 
detection for the proposed method was 5 ng mL-1, with the exception of MDPV, which was 
20 ng mL-1and the limit of quantification was 20 ng mL-1, with the exception of MDPV, which 
was 50 ng mL-1. The findings prove a valid detection method was developed, sensitive 
enough to detect a small concentration in a urine sample, which could be useful for forensic 
science laboratories analysing biological samples containing the synthetic cathinone’s 
studied. Although the method was successful in the detection of the given synthetic 
cathinone’s, the technique of GC-MS can only be used within a laboratory setting and does 
not provide quick in-the-field results. Further work in 2018 researched the discrimination of 
synthetic cathinone’s by GC-MS and GC-MS/MS using cold electron ionization by Levitas et 
al26 in which classical and cold electron ionization were compared. For the 35 synthetic 
cathinone’s tested in this study there was a noticeable improvement in the molecular ion 
relative intensity and in many cases cold electron ionization yielded additional fragment ions 
compared to classical electron ionization. Other analytical techniques have been explored 
by researchers: in 2013 Mabbott et al27 used surface enhanced Raman scattering (SERS) 
which again shows a technique that can successfully detect cathinone’s in a laboratory 
based setting, but can not be used to produce quick, reliable results in-the-field. 
 
A different analytical technique was explored by LaPointe et al28 by using direct analysis in 
real time mass spectrometry (DART-MS) to characterize and analyse three synthetic 
cathinone’s and three metabolites in urine without any sample preparations. The method of 
DART-MS analysis proved successful in detecting and characterizing the cathinones and its 
metabolites with speed and efficiency at clinically relevant levels (ng mL-1) in urine. The 
detection of the synthetic cathinone’s in urine without sample preparation is a great 
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development as this can be used to further explore the possibility of a sensor that can be 
used by frontline workers who deal with biological samples. However, the technique of 
DART-MS is laboratory based and will not be able to be used in-the-field as a portable 
sensor. 
Traditional analytical techniques have clearly proved successful by many researchers, with 
the use of HPLC and GC-MS with LC-MS being the most common choice; however, law 
enforcements require a method that is adaptable to become a portable in-the-field device, 
producing the same or even better sensitivity to small concentrations. Electrochemistry is a 
branch of chemistry recently explored in regards to the detection of new psychoactive 
substances: it is an advantageous analytical tool as it has the potential to work as an in-the-
field device given its fast and reliable response, as well its portability in comparison to an 
offsite laboratory method. 
1.2.1   Electrochemistry 
Electrochemistry studies the relationship between electron transfer and chemical change: 
electrochemical reactions involve the transfer of charge from a charged species across an 
electrode to a solution phase species. The energy of the charged species is dependent on 
the potential of the phase the species is in: a potential is set up across the two phase when 
a metal is partly immersed in an electrolyte i.e. an electrode/electrolyte interface (or a 
solution/electrode interface)29. As electrons move towards the equilibrium a net charge 
separation is developed and a potential difference is created across the interface of the two 
phases (at the solution/electrode interface) as the charge transfer occurs. The potential 
difference is measured by the use of a circuit consisting of a surface/electrode interface and 
a reference electrode that maintains a fixed potential difference. The electrochemical cell 
setup usually involves the use of three electrodes: a working electrode, a counter electrode 
and a reference electrode connected to the potentiostat, which controls the potential 
difference between the reference and counter electrode. The working electrode is where 
the reaction of interest occurs, which are commonly made of inert materials such as Au, Pt, 
glassy carbon and Ag etc. The counter electrode is a non-reactive high surface area 
electrode used to close the current circuit in the electrochemical cell, which is usually made 
of inert materials such as Pt, Au and Graphite. The reference electrode has a well-known 
electrode potential and is used as the point of reference for the potential control and 
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measurement30. Since the 1990s31, screen-printing technology has produced inexpensive 
and highly reproducible single-use sensors, which is ideal for a portable in-the-field device. 
The application of this technology to electrochemical detection allows all three electrodes 
to be combined onto one surface to create a screen-printed electrode (SPE) which is 
portable, economical and disposable. Graphene has been explored as a highly promising 
material for electrochemical sensing and is used to make screen-printed graphene 
electrodes: graphene possesses a much larger specific surface area (2630m2 g-1) and an 
excellent electrical conductivity (7200 Sm-1) compared with other carbon materials32. This is 
useful as a larger surface area is required for the counter electrode, so that it is higher than 
the area of the working electrode and will not be a limiting factor in the kinetics of the 
electrochemical process.  
 
In 2012 by Krishnaiah et al33 were the first researchers to report the electrochemical 
behaviour of a synthetic cathinone: the study focused on mephedrone in basic conditions 
using a mercury dropping electrode. An analytical range of 2.7 x 10-4 to 1.8 µg mL-1 with a 
detection limit of 2.2 x 10-3 µg mL-1 was reported. Although the study was successful in 
reporting the electrochemical behaviour of mephedrone, the use of mercury is not practical 
for a portable device, as it is considered a harmful chemical34. To further develop this work 
and explore the use of electrochemistry in the detection of synthetic cathinone’s, Smith et 
al35 researched the effect of scan rate of pH on the detection of methcathinone 
mephedrone and 4′-methyl-N-ethylcathinone (4-MEC). All three cathinone’s were 
electrochemically detected using boron-doped diamond, glassy carbon and screen-printed 
graphite macroelectrodes in a range of buffers: limits of detection for methcathinone, 
mephedrone and 4′-methyl-N-ethylcathinone (4-MEC) were 44.5, 39.8 and 84.2 µg mL-1 
respectively. The study shows for the first time the electrochemical detection of the 
cathinone class and proves that the electrochemical technique provides useful analytical 
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1.2.2.   Aims  
This project will aim to detect and quantify both N-ethylpentylone and MDPHP 
electrochemically using techniques such as cyclic voltammetry and differential pulse 
voltammetry. Reference standards and corresponding street samples of N-ethylpentylone 
and MDPHP will be fully characterised using 1H- and 13C-NMR, gas chromatography-mass 
spectrometry (GC-MS) and infrared spectroscopy. Once characterised, an electrochemical 
detection method will be developed and validated (vs. GC-MS) for both N-ethylpentylone 
and MDPHP using cyclic voltammetry and differential pulse voltammetry. Once the methods 
have been validated, the street samples (provided by law enforcement agencies) will be 
utilised to determine the applicability of the optimised electrochemical method for the 
quantification of the two target analytes in real-world samples. As there is little research 
and information in regards to N-ethylpentylone, it is necessary that this thesis aims to 
successfully detect the drug and this can be used as the basis for future developments.  
The detection of MDPHP will be tested using electrochemical techniques, due to the high  
number of seized samples across the country it is apparent that is necessary to investigate 
the possibility that MDPHP may be detected in a biological sample using an electrochemical 
technique. If the detection of MDPHP is shown to be successful in a biological sample in this 
thesis, this will be further investigated and developed in the future. The primary focus of 
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Figure 4. Electrochemical properties of a synthetic cathinone 
Figure 4 shows the detailed electrochemical properties of a synthetic cathinone which 
outlines the no. of electrons transferred in the oxidation and reduction process. This is 
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2. Experimental  
2.1. General Details  
All chemicals used were used as received from Sigma-Aldrich (Gillingham, U.K) and were of 
analytical grade. Solutions were prepared with deionized water of resistively no less than 
18.2 Ω cm, unless otherwise stated, and were vigorously degassed with nitrogen to remove 
oxygen prior to analysis for a minimum of 40 minutes. Regarding the drugs used reference 
materials were either prepared in-house or obtained, under UK Home Office licence, by 
authorised personnel and in compliance with both the UK Misuse of Drugs Act (1971) and 
UK Misuse of Drugs Regulations (2001). Test samples (street samples) were provided by 
Greater Manchester Police (GMP) personnel, in accordance with the legislation and under 
the approved Memorandum of Understanding operating between the MANchester DRug 
Analysis and Knowledge Exchange (MANDRAKE) and GMP. All controlled/restricted 
materials were stored, transferred, used and destroyed in compliance with the UK Misuse of 
Drugs Act (1971) and UK Misuse of Drugs Regulations (2001). The voltammetric 
measurements were recorded using an ‘Autolab PGSTAT 101’ (Metrohm Autolab, The 
Netherlands) computer-controlled potentiostat with the Nova 2.0 software. Experiments 
were performed using screen-printed graphite macroelectrodes (SPEs) which have a 3mm 
diameter working area which were produced in-house with appropriate stencil designs using 
a DEK 248 screen-printing machine (DEK, Weymouth, U.K.). The SPE’s were characterized 
and reported previously within literature1. The reproducibility of the batch within literature 
of screen printed electrodes were found to be 0.76%36 relative standard deviation (RSD) 
using the Ru(NH3)2+/3+ redox probe in 1M KCL. The heterogeneous rate constant, ko for the 
Ru(NH3)2+/3+ redox probe in 1M KCL was found to be 2.12 × 10−3  cm s−1. 
Gas Chromatography – Mass Spectrometry (GC-MS) analysis was performed on an Agilent 
7890B GC coupled to an Agilent 5977B Mass Spectrometer (Agilent Technologies, Cheadle, 
UK).  GC-MS parameters: Carrier Gas: He; Flow-rate: 1.2 mL/min Column: HP5-MS column 
(30 m x 0.25 mm x 0.25 μm); MS Range (Scan Mode): 40-550 m/z at 5.4 scans/sec.  Injection 
Volume: 0.5 μL injection (1 mg/mL); Split Ratio: 50:1; Inlet & Transfer Line Temperature: 
265°C. Temperature programme: Hold time of 3 minutes at 50°C, ramp at 30°C/min for 8 
minutes, then hold for 6 minutes.  
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2.2. Determination of Method’s 
Prior to preparing solutions and recording electrochemical measurements using the NEP and 
MDPHP samples, the methods used were determined using previously stated methods from 
literature. The two methods used to determine parameters and ensure the system was 
working correctly are stated in the following sections.  
2.2.1. Preparation of standard stock solutions and calibration plot solutions for 
determination of cyclic voltammetry method: mephedrone (4-MMC)  
Four stock solutions of 1000 µg mL-1 mephedrone (4-MMC control) were made by weighing 
out 10 mg into 10mL volumetric flasks, and were made up to the mark with the following 
buffer solutions: acetate buffer pH 2, 5.5, 9 and 12. All solutions were diluted to achieve the 
following concentrations: 500, 400, 250,200,125 and 100 µg mL-1  of 4-MMC. 25 µg mL-1 of 
each respective solution was applied to the SPE, which was attached to the potentiostat. 
The cyclic voltammograms were recorded in the range of 0.2 to -1.6 V using a scan rate of 
0.05 V/s. This was repeated three times per each pH buffer solution and concentration.   
2.2.2. Preparation of standard stock solutions and calibration plot solutions for 
determination of differential pulse voltammetry method: absorbic acid  
A stock solution of 1mM absorbic acid was prepared by weighing out 1 mg into a 10 mL 
volumetric flask, made up to the mark by pH 4 phosphate buffer solution. The SPE was fully 
immersed into the solution and differential pulse voltammograms were recorded using the 
following conditions: modulation amplitude: 0.07 V; modulation time 0.07 s; interval time: 
0.7 s; step: -0.005 V and scan rate: 0.5 V/s.  
2.3. MDPHP  
A sample of control MDPHP and six street samples containing MDPHP were used for the 
following experiments, the street samples were labelled as: D15, D16, D19, T1D, T4B and 
T2C. A 2500 µg mL-1 stock solution of MDPHP (control) and (each street sample) were made 
by weighing out 25 mg respectively into 10 mL volumetric flasks and made up to the mark 
using 0.1 M acetate buffer at pH 5.5 (unless stated otherwise): this was made fresh for each 
of the following experiments. Each electrochemical measurement was repeated three times 
with a new SPE used each time. Based on previous literature36, the expected optimum value 
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is between 250 µg mL-1 and 500 µg mL-1 for the detection of synthetic cathinone’s. In order 
to ensure a linear measurable range, the greatest concentration tested will be 1000 µg mL-1 
and this will be tested in reduced increments in order to determine the optimum 
concentration for the detection of MDPHP. In regards to the limit of detection, previous 
literature18 shows the lowest concentration in a biological sample to be detected is 7 µg mL-
1, therefore concentrations lower than this will be tested to attempt to detect MDPHP at a 
lower concentration using electrochemical techniques.  
2.3.1. Preparation of standard stock solutions and calibration plot solutions for 
cyclic voltammetry (CV): MDPHP Control Sample 
Two MDPHP stock solutions were made by weighing out 8 mg and 5 mg in 1 mL vials, which 
was made up to the mark using 0.1 M acetate buffer pH 4.3, to make an 800 µg mL-1 and 
500 µg mL-1 solution respectively. Both were serially diluted with 0.1 M acetate buffer pH 
4.3 to the concentrations 800, 500, 400, 250, 200, 125, 100, 62.5, 50, 31.25, 25 and 10 µg 
mL-1 of MDPHP. 25 µg mL-1 of each respective solution was applied to the SPE, which was 
attached to the potentiostat. The cyclic voltammograms were recorded in the range 0 to -2 
V, using 0.05 V/s. This process was repeated three times using three different pH acetate 
buffers: pH 5.5, pH 9 and pH 12.  
2.3.2. Preparation of standard stock solutions and calibration plot solutions for 
differential pulse voltammetry (DPV): MDPHP Control Sample 
5000 µl of the 2500 µg mL-1 stock solution of MDPHP (control) was put into a glass vial and 
then diluted to the following concentrations using 0.1 M acetate buffer pH 5.5: 1000, 900, 
800, 700, 600, 500, 400, 300, 200 and 100 µg mL-1. The SPE was fully immersed into the 
solution and differential pulse voltammograms were recorded using the following 
conditions: modulation amplitude: 0.15 V; modulation time 0.15 s; interval time: 0.2 s; step: 
-0.005 V and scan rate: 0.025 V/s. This process was repeated three times. 
2.3.3. Preparation of standard stock solutions and calibration plot solutions for 
cyclic voltammetry (CV): MDPHP street samples 
5000 µl of the stock solution of MDPHP (street sample) was put into a glass vial and then 
diluted to the following concentrations: 1000, 900, 800, 700, 600, 500, 400, 300, 200 and 
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100 µg mL-1. The SPE was fully immersed into the solution and cyclic voltammograms were 
recorded in the range of 0 to -2 V, using the 0.05 V/s. This process was repeated for each 
street sample, three times.  
 
2.3.4. Preparation of standard stock solutions and calibration plot solutions for 
cyclic voltammetry (CV): MDPHP street samples spiked with adulterants 
Three adulterants were tested in the following experiment: paracetamol, benzocaine and 
caffeine. 5000 µl of the 2500 µg mL-1 stock solution of MDPHP (street sample) was put into a 
glass vial and diluted to 500 µg mL-1 using the 0.1 M acetate buffer pH 5.5. 500 µg (5 mg) of 
one adulterant was added into the solution and the SPE was fully immersed into the 
solution: cyclic voltammograms were recorded in the range of 0 to -2 V, using scan rate 0.05 
V/s. The adulterant was changed, to ensure each street sample was tested with each 
adulterant.  
2.3.5. Preparation of standard stock solutions and calibration plots for cyclic 
voltammetry (CV): MDPHP in Urine Solution-Calibration and Limit of 
Detection  
Calibration: A stock solution of urine was made by adding 5 mL of urine into a 100 mL flask 
and made up to the mark with 0.1 M acetate buffer. 5000 µL of the urine stock solution was 
put into a glass vial, 200 µL was taken out and 200 µL of the 2500 µg mL-1 stock solution of 
MDPHP (control) was put in to give a concentration of 100 µg mL-1. This process was 
repeated to achieve concentrations of 200, 300, 400, 500, 600, 700, 800, 900 and 1000 µg 
mL-1. The SPE was fully immersed into the solution and cyclic voltammograms were 
recorded in the range of 0 to -2 V, using 0.05 V/s.  
Limit of Detection: A new 50 µg mL-1 stock solution (labelled “R1”) was made by pipetting 2 
mL of the 2500 µg mL-1 MDPHP (control) stock solution into a 100 mL volumetric flask, 
which was made up to the mark with 0.1 M acetate buffer pH 5.5. 5000 µL of the urine stock 
solution was pipetted into a glass vial and 100 µL was taken out and 100 µL of the “R1” 
solution was added in to achieve a concentration of 1 µg mL-1. This was repeated to achieve 
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concentrations, 2,3,4,5,6 ,7 and 8 µg mL-1. The SPE was fully immersed into the solution and 
cyclic voltammograms were recorded in the range of 0 to -2 V, using 0.05 V/s.   
 
2.3.6. Preparation of standard stock solutions and calibration plots for cyclic 
voltammetry (CV): MDPHP street sample quantification  
A 2600 µg mL-1 stock solution of MDPHP (control) was made by adding 26 mg MDPHP 
(control) into a 10 mL volumetric flask, which was made up to the mark with pH 5.5 acetate 
buffer. 5000 µL of the solution was added to a glass vial and further diluted to achieve 
concentrations 2500, 2400, 2300, and 2000 µg mL-1. The SPE was fully immersed into the 
solution and cyclic voltammograms were recorded in the range of 0 to -2 V, using 0.05 V/s. 
Next, 5000 µL of each 2500 µg mL-1 MDPHP (street sample) stock solution was pipetted into 
a separate glass vial and cyclic voltammograms were recorded in the range of 0 to -2 V, 
using 0.05 V/s. When making the 2500 µg mL-1 MDPHP (street sample) stock solutions for 
this experiment it was necessary to record the accurate mass of each street sample used in 
order to calculate the percentage quantification.  
 
2.4. NEP 
A sample of control NEP and four street samples containing NEP were used for the following 
experiments, the street samples were labelled as: SS1, SS2, SS3 and SS4. A 2500 µg mL-1 
stock solution of NEP (control) and (each street sample) were made by weighing out 25 mg 
respectively into 10 mL volumetric flasks and made up to the mark using 0.1 M acetate 
buffer at pH 5.5 (unless stated otherwise): this was made fresh for each of the following 
experiments. Each electrochemical measurement was repeated three times with a new SPE 
used each time. Based on previous literature36, the expected optimum value is between 250 
µg mL-1 and 500 µg mL-1 for the detection of synthetic cathinone’s. In order to ensure a 
linear measurable range, the greatest concentration tested will be 1000 µg mL-1 and this will 
be tested in reduced increments in order to determine the optimum concentration for the 
detection of NEP. 
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2.4.1. Preparation of standard stock solutions and calibration plots for cyclic 
voltammetry (CV); NEP Control Sample pH study  
Seven solutions of NEP (control) were prepared by weighing out 0.005 g into 10 mL 
volumetric flasks, and were made up to the mark with the following buffer solutions: 
acetate buffer at pH 4.3, 5.5, 9 and 12 and phosphate buffer solution at pH 6, 7 and 8. 25 µg 
mL-1  of each respective solution was applied to the SPE, which was attached to the 
potentiostat. The cyclic voltammograms were recorded in the range 0 to -2 V, using 0.05 
V/s. This was repeated three times per each pH buffer solution.  
 
2.4.2. Preparation of standard stock solutions and calibration plots for cyclic 
voltammetry (CV): NEP Control Additions study 
Four stock solutions of NEP (control) were made by weighing out 10 mg into 10 mL 
volumetric flaks, and were made up to the mark with the following buffer solutions: acetate 
buffer pH 4.3, 5.5, 9 and 12. Each solution was diluted to achieve the following 
concentrations: 1000, 500, 100, 50, 10, 5 and 1 µg mL-1. 25 µg mL-1 of each respective 
solution was applied to the SPE, which was attached to the potentiostat. The cyclic 
voltammograms were recorded in the range 0 to -2 V, using 0.05 V/s. This was repeated 
three times per each pH buffer solution and concentration.   
 
2.4.3. Preparation of standard stock solutions and calibration plots for cyclic 
voltammetry (CV); NEP Street sample  
Two NEP stock solutions (per street sample) were made by weighing out 8 mg and 5 mg in 1 
mL vials, which was made up to the mark using 0.1 M acetate buffer pH 5.5, to make an 800 
µg mL-1 and 500 µg mL-1 solution respectively. Both were serially diluted with 0.1 M acetate 
buffer pH 5.5 to the concentrations 800, 500, 400, 250, 200, 125, 100, 62.5, 50, 31.25, 25 
and 10 µg mL-1of MDPHP. 25 µg mL-1of each respective solution was applied to the SPE, 
which was attached to the potentiostat. The cyclic voltammograms were recorded in the 
range 0 to -2 V, using 0.05 V/s. This process was repeated four times to ensure each NEP 
street sample was tested.  
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2.4.4. Preparation of standard stock solutions and calibration plot solutions for 
differential pulse voltammetry (DPV): NEP control sample  
Two NEP stock solutions (control) were made by weighing out 8 mg and 5 mg in 1 mL vials, 
which was made up to the mark using 0.1 M acetate buffer pH 5.5, to make an 800 µg mL-1 
and 500 µg mL-1 solution respectively. Both were serially diluted with 0.1 M acetate buffer 
pH 5.5 to the concentrations 800, 500, 400, 250, 200, 125, 100, 62.5, 50, 31.25, 25 and 10 µg 
mL-1 of MDPHP. The SPE was fully immersed into the solution and differential pulse 
voltammograms were recorded using the following conditions: modulation amplitude: 0.17 
V; modulation time 0.17 s; interval time: 0.25 s; step: -0.05 V and scan rate : 0.02 V/s. This 
















28 | P a g e  
 
3. Discussion  
3.1. Validation of System 
In order to benchmark the system and ensure optimisation of the electrode, a scan rate 
study using ruthenium salt was performed by following methodology stated in previous 
literature. The effect of voltammetric scan rate on the size of peak current was analysed and 
as shown in Figure 5 (A), as the voltammetric scan rate was increased, the size of the peak 
current increased. This is due to the relationship between the diffusion layer and scan rate: 
a faster scan rate results in a shorter diffusion layer, which then provides a greater size of 
peak current. The scans also show a variation of peak position: as the voltammetric scan 
rate increases the peak potential becomes more positive, which suggests the process is 
electrochemically quasi-reversible.  
 
Figure 5 (A) Ruthenium scan rate study (0.005 V s-1 to 0.5 V s-1) showing the voltammetric 
responses of 1mM ruthenium in 1M KCl using screen-printed graphite macroelectrodes (vs. 
Ag/AgCl). Figure 5 (B) Potassium ferrocyanide(II)  scan rate study (0.015 V s-1 to 0.5 V s-1) 
showing the voltammetric responses of 1mM potassium ferrocyanide(II) in 0.1M KCl using 
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To determine how fast the electron is transferring the difference between reduction and 
oxidation potentials was found and the heterogeneous rate constant,Κ𝑜, was calculated by 
applying the Nicholson method described in equation 1 and 2. The calculated Κ𝑜value is  
2.12 × 10−3cm s−1 which is similar to the literature value of 3.36 × 10−3 cm s−136., therefore 
it ensures that the system is working correctly and there is confidence in the system.  
The area of the electrode that is reactive was calculated by performing a voltammetric scan 
rate study using potassium ferrocyanide (II) as shown in figure 5 (B) .  
Κo = Ψ(2.49 × 10−6 × π × 0.1 × (1859.802) × 1) 
  Equation 1.   Nicholson’s Equation used to calculate the heterogeneous rate 
constant, 𝛫𝑜.  𝛹(∆𝐸𝑝) is the peak to peak separation in mV and can be 
calculated using equation 2 
 
𝜓 = (−0.6288 + 0.0021𝑋)/(1 − 0.017𝑋) 
  Equation 2.   Peak to peak separation, which fits Nicholson’s data 
 
0.630237109 (2.49 × 10−6 × π × 0.1 × (1859.802) × 1) = 2.12 × 10−3cm s−1 
  Equation 3.   Heterogeneous rate constant, 𝛫𝑜 calculation 
 
The Randles-Sevcik equation (equation 4) was used to calculate the area of the electrode 
based upon peak current, which was found to correspond to 0.013cm2, the geometric area 
of the electrode is found by 𝐴 = 𝜋𝑟2 = 0.071cm2. The calculated area is significantly less 
than the geometric area as the carbon ink contains polymers that are not reactive, which 
makes parts of the electrode unreactive. The Randles-Sevcik equation (equation 4) can also 
be used to describe how the peak current increases linearly with the square root of the scan 
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rate, which means the reaction is diffusional based. This means that if some of the analyte 
diffuses on the surface there will be excess, rather than the analyte adsorbing onto the 
surface of the electrode, which leads to deviation from linearity in the plot of peak current 









Equation 4. The Randles-Sevcik equation describes how peak current is related to 
scan rate and can also be used to calculate the area of the electrode and 
diffusion coefficients.  Where, ip is the peak current in amperes, A is the 
electrode area in cm2, 𝐷𝑜 is the diffusion coefficient in cm
2 s–1, 𝐶0 is the 
concentration in mol cm–3, and 𝒗 is the sweep rate in V s–1 
 
As previous research has been conducted by Smith et al in regards to the electrochemical 
detection of mephedrone, which is a popular cathinone, the method used by the 
researchers was investigated to ascertain the relevance to the electrochemical detection of 
N-ethylpentylone.  
The electrochemical reduction response of 500 µg mL-1 mephedrone in 0.1 M acetate buffer 
solution was studied over the pH range 2 – 12 as shown in figure 6 (A): the reduction peak is 
not apparent in an acidic environment (pH 2), but is well defined in a more neutral 
environment (pH 5.5). The peak shape and intensity of the peak is shown to change in 
different pH environments: the reduction peak is not apparent in an acidic environment (pH 
2), and is the most defined and intense in a neutral environment (pH 5.5). The peak intensity 
decreases and becomes less defined in a basic environment (pH 9 and pH 12).  Therefore, 
pH 5.5 is the optimum acetate buffer for the electrochemical reduction of mephedrone. 
Following this, figure 6 (B) shows the electrochemical response of a range between 500 – 
100 µg mL-1 mephedrone in 0.1 M acetate buffer solution pH 5.5: the size of the peak 
current decreases proportionally to the decrease in concentration of mephedrone, which is 
also shown in figure 6 (C). This suggests that the peak detected is dependent on 
concentration. To ensure confidence in the method, the optimum pH and limit of detection 
was compared: the results show that pH 5.5 is the optimum pH and in the literature pH 4.3 
was used, which is close in acidity therefore concurrent. The calculated limit of detection is 
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equal to 39.18 µg mL-1 which can be compared to the literature value of 39.8 µg mL-1 36. The 
sensitivity is equal to 2 x 10-8 µg mL-1. As the results found in this investigation are similar to 
the results reported in the literature, the method is shown to be successful and can be used 


























































Figure 6 (A) Cyclic voltammograms showing the electrochemical response of 500 
µg mL-1 mephedrone in 0.1 M acetate buffer at pH 2 (blue), 5.5 (orange), 9 
(grey) and 12 (yellow) using screen-printed graphite macroelectrodes (vs. 
Ag/AgCl). (B) Cyclic voltammograms showing electrochemical response of 
500 – 100 µg mL-1 mephedrone in 0.1 M acetate buffer solution pH 5.5 
using screen-printed graphite macroelectrodes (vs. Ag/AgCl). (C) Linear 
calibration plot showing the relationship between concentration of mephedrone 
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3.2. N-ethylpentylone Results 
 
To determine the optimum conditions for the electrochemical detection of N-
ethylpentylone, the electrochemical reduction response was investigated in acetate and 
phosphate buffer solution (PBS) over a range of pH’s and concentrations.  
 
3.2.1. Control Sample in Acetate Buffer  
 
Figure 7. Cyclic voltammogram showing the electrochemical response of 500 µg 
mL-1 N-ethylpentylone in 0.1 M acetate buffer at pH 5.5 using screen-printed 
graphite macroelectrodes (vs. Ag/AgCl).  
The electrochemical response of 500 µg mL-1 N-ethylpentylone in 0.1 M acetate buffer was 
studied at pH 5.5 as shown in figure 7 as pH 5.5 was previously determined as the optimum 
condition during validation of the system. A scan was performed over the range 1 to -2 V 
which shows a visible oxidation peak at ≈ 0.64 V and a reduction peak at ≈ -1.4V. There is 
also a visible residual oxygen peak at -1 V although the solution was thoroughly degassed 
using nitrogen. The reduction peak has a greater peak intensity in comparison to the 
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in future studies. As the chemical process is unknown, the process will be optimised by 
conducting a pH study.  
 
3.2.2. pH Study  
 
Figure 8 (A) Cyclic voltammograms showing the electrochemical response of 500 
µg mL-1 N-ethylpentylone in 0.1 M acetate buffer at pH 4.3 (blue), 5.5(orange), 
9(grey) and 12 (yellow) using screen-printed graphite macroelectrodes (vs. 
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It was observed in figure 8 (B) that the NEP peak position shifts to a more negative potential 
as the pH is increased to a more basic medium, indicating the electrochemical reduction of 
NEP is a pH dependent process. The change in pH may affect the electrochemical reduction 
of NEP, resulting in a difference in peak position, as the concentration H+ and OH- ions are 
altered in the various pH solutions. The peak currents show that pH 5.5 is the optimum pH 
for the detection of the reduction peak, therefore an additions study was conducted using 
the optimum pH. Fig 8 (B) shows a plot of peak position against pH, with a gradient of 57 
mV, which is close to the theoretical value of 59mV in literature by Wu et al , indicating an 
electrochemical process involving an equal number of electrons and protons. 
 
3.2.3. Additions Study 
 
The effect of the N-ethylpentylone concentration on peak current was studied in the optimum pH 
5.5 0.1 M acetate buffer, figure 9 (A) shows cyclic voltammograms produced and figure 9 (B) shows 

























Figure 9 (A) Cyclic voltammograms showing the electrochemical response of 1 – 
1000 µg mL-1 N-ethylpentylone in 0.1 M acetate buffer at pH 5.5 using screen-
printed graphite macroelectrodes (vs. Ag/AgCl). (B) Overlay of calibration plots 
showing peak height vs concentration of NEP in 0.1 M acetate buffer at pH 4.3, 
5.5, 9 and 12. 
Figure 9 (A) shows the cyclic voltammograms produced at each concentration and displays 
that the higher concentrations yielded higher reduction peak intensities. At the highest 
concentration of 1000 µg mL-1 the peak shape is less defined in comparison to the peak 
produced at 500 µg mL-1 . An overlay of calibration plots showing peak current vs 
concentration in figure 9 (B) shows that as the pH increases to a more basic medium, the 
peak current decreases. The change in calibration curves constructed at each pH can be 
explained by the change in cathinone stability. Previous work conducted by Tsujikawa et 
al37, investigated the stability of five synthetic cathinone’s over a range of pH and found that 
the drug stability increased as the pH decreased. This explains the results found at the most 
basic pH, 12, as the analyte most likely degraded in the basic media which results in poor 
peak currents in comparison to the peak currents in the optimal acidic media.  
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3.2.4. Scan Rate Study  
The effect of scan rate upon the electrochemical reduction of 500 μg mL-1 NEP in pH 5.5 
acetate buffer was investigated. 
 
 
Figure 10(A). Calibration plot showing the relationship between Peak height and 
Square root of scan rate of 500 µg mL-1 MDPHP in 0.1 M acetate buffer at pH 5.5 
using screen-printed graphite macroelectrodes (vs. Ag/AgCl). (B) Calibration plot 
showing relationship between Log (peak height) and Log (scan rate) of 500 µg mL-
1 MDPHP in 0.1 M acetate buffer at pH 5.5 using screen-printed graphite 
macroelectrodes (vs. Ag/AgCl). 
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A plot of ‘peak height’ against the square root of scan rate/ was found to be linear which 
indicates a diffusional process, as indicated with the following regression equation Ip/A = -
2.502 x 10-5 A (V s-1)1/2 + 2.31 x 10-8 A; R2 = 0.998 (Figure 10 A). When plotting log peak 
height against log scan rate, a gradient close to 0.5 was found (Figure 10 B). A gradient of 
0.5 also indicates a diffusional process, as indicated with the following regression equation 
log Ip / logA = 0.526 log A (log V s-1) – 4.582 log A; R2 = 0.995. 5 points are used in the 




The electrochemical response of 1-1000 µg mL-1 N-ethylpentylone in 0.1 M phosphate 
buffer solution was studied over the pH range 6 – 8 as shown in figure 11. It was observed 
that the NEP peak potential shifts towards a more negative potential and the peak intensity 
decreases when the pH is increased to a more basic environment. The electrochemical 
reduction of NEP is possible in all three mediums of PBS, but all peaks appear to have a 
background peak visible which results in a less defined peak shape.  
 
Figure 11. Cyclic voltammograms showing the electrochemical response of 500 
µg mL-1 N-ethylpentylone in 0.1 M PBS at pH 6 (blue), 7 (orange) and 8 (grey) 
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3.2.6. Comparison of Electrochemical Response of NEP in acetate and PBS 
 
The electrochemical reduction is shown to be viable in both acetate buffer and phosphate 
buffer, the most prominent peaks from both studies are compared in figure 12. Although pH 
6 was the optimum environment in PBS, the peak shape is more defined and intense in pH 
5.5 acetate buffer. 
 
 
Figure 12. Comparison of cyclic voltammograms showing the electrochemical 
response of N-ethylpentylone in 0.1 M acetate buffer at pH 5.5 and 0.1 M PBS at 
pH 6 using screen-printed graphite macroelectrodes (vs. Ag/AgCl). 
The reduction peak is visibly more defined and the peak intensity is greater in the pH 5.5 
acetate buffer in comparison to the pH 6 PBS. Given the results from each study, it can be 
concluded that pH 5.5 acetate buffer is the optimum environment for the electrochemical 
reduction of NEP and will be used in further studies. There are also visible oxidation peaks in 
all the voltammetric responses, however the reduction peak was focused upon as the peak 
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40 | P a g e  
 
3.2.7. Detection of NEP (Street Samples) in acetate  
The electrochemical responses of four different 500 µg mL-1 N-ethylpentylone Street 
Samples, (referred to as “SS1”, “SS2”, “SS3” and “SS4”), in 0.1 M acetate buffer pH 5.5 were 
studied using cyclic voltammetry. A set concentration and pH were used in this part of the 
study as the aim was to determine whether the street samples contained NEP and could be 
electrochemically reduced.  
 
Figure 13 (A) Cyclic voltammograms showing the electrochemical response of N-
ethylpentylone street samples (SS1(green), SS2(dark blue), SS3(yellow) and 
SS4(grey)), control sample (orange) and blank buffer (blue) in 0.1 M acetate 
buffer at pH 5.5 using  screen-printed graphite macroelectrodes (vs. Ag/AgCl). 
Figure 13 (A) shows that each street sample contains NEP as the electrochemical reduction 
peak appears at a similar potential as the control NEP sample. Electrochemical oxidation 
peaks appear in the positive potential region, however the reduction peaks will be focused 
upon as the peak intensities are greater. For the next part of the study, the electrochemical 
response of one street sample, SS1, in 0.1 M acetate buffer pH 5.5 was explored over a 
concentration range of 10 – 800 µg mL-1. Figure 13 (B) shows a plot of NEP peak height 
(Ip/units) against concentration (µg mL-1) which generates a linear plot between the range 



























Figure 13 (B) Linear calibration plot of peak height (Ip) against concentration of 
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3.2.8. NEP Spiked samples- adulterants 
 
The selectivity of the method was tested in order to determine if commonly found 
adulterants in street samples affected the electrochemical response of NEP. Cyclic 
voltammograms were recorded of each street sample spiked with three common 
adulterants separately: paracetamol, caffeine and benzocaine. Cyclic voltammograms were 
recorded for each sample in the potential window 0 to -2 V to focus on the region that the 
electrochemical response of NEP was previously detected. 
 
 
Figure 14. Cyclic voltammograms showing the electrochemical response of N-
ethylpentylone SS1 spiked separately with 500µg of caffeine (blue), benzocaine 
(orange) and paracetamol (grey) in 0.1 M acetate buffer at pH 5.5 using  screen-
printed graphite macroelectrodes (vs. Ag/AgCl). 
The voltammograms of  the NEP street sample (SS1) spiked with each adulterant are shown 
in figure 14: each adulterant shows a small oxidation peak at approximately -0.75 V, which 
indicates that there will be little interference with the electrochemical response of the 
reduction peak of NEP at 1.5 V. The expected reduction peak of NEP is visible and the 
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3.2.9. Detection of NEP (Control) in Acetate using DPV 
 
Differential pulse voltammetry (DPV) is an advantageous technique as it provides more 
sensitive results in comparison to cyclic voltammetry. DPV measures the difference between 
two currents and the modulation amplitude is kept constant which subtracts the 
contribution of the non-faradaic processes. Therefore, peaks are well-resolved and are 
typically sharper than peaks found using cyclic voltammetry. The electrochemical reduction 
of 25 – 500 µg mL-1 N-ethylpentylone (control) in 0.1 M acetate buffer pH 5.5 was studied 
using differential pulse voltammetry in attempt to improve sensitivity as reported by 
Elbardisy et al38. during the electrochemical sensing of mephedrone metabolites. Conditions 
were firstly optimised and the optimum conditions were found to be: modulation 
amplitude: 0.17 V; modulation time 0.17 s; interval time: 0.25 s; step: -0.05 V and scan rate: 
































Figure 15 (A) Differential pulse voltammograms showing the electrochemical 
response of N-ethylpentylone in 0.1 M acetate buffer at pH 5.5 using  screen-
printed graphite macroelectrodes (vs. Ag/AgCl). (B) Linear calibration plot of peak 
height against concentration of N-ethylpentylone. N=3.  
Figure 15 (A)  shows that as the concentration of NEP is increased, the peak intensity 
increases and the peak potential generally shifts very slightly to a more negative potential 
due to a larger concentration of NEP at the surface electrode. The peak shape becomes  
more defined as the concentration increases and is not a symmetrical curve as expected 
with the technique of DPV. In comparison to the peaks shown using CV in figure 9 (A), the 
peaks are more defined as expected. An asymmetrical peak is usually attributed to an 
irreversible reaction, however this is not concurrent with the findings using CV as the peaks 
generated suggests a reversible reaction. Figure 15 (B) shows a plot of peak height (Ip/µA) 
against concentration (µg mL-1) generates a linear calibration plot between the range of 25 – 
500 µg mL-1 with the R2 value of 0.985. The Limit of Detection was calculated to be 0.130 µg 
mL-1  and the RSD  is 5.85%. 
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3.2.10. Comparison of CV and DPV Findings  
 
Both techniques of cyclic voltammetry and differential pulse voltammetry were compared in 
the electrochemical reduction of N-ethylpentylone.  
The electrochemical responses recorded from the technique of cyclic voltammetry and 
differential pulse voltammetry were compared in order to ascertain the most sensitive 
method for the electrochemical reduction of MDPHP.  
 
 
Figure 16. Comparison of linear calibration plots from cyclic voltammetry and 
differential pulse voltammetry techniques, showing peak height against 
concentration of N-ethylpentylone in 0.1 M acetate buffer.   
Figure 16 shows a comparison of the linear calibration plots constructed for the NEP peak 
height (Ip/µA) against concentration (µg mL-1), using cyclic voltammetry (CV) and differential 
pulse voltammetry (DPV). Using the standard error of the slope generated, the limit of 
detection was calculated to be 0.130 µg mL-1 and 0.104 µg mL-1 for DPV and CV respectively. 
According to literature, DPV is the more sensitive method which typically results in a lower 
limit of detection: the study conducted does not reflect this and shows a more linear 
y = -3.09E-08x - 2.17E-06
R² = 9.85E-01
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relationship between peak height and concentration, and a lower LOD. Therefore, cyclic 
voltammetry was the preferred technique of use for the remaining experiments.  
3.2.11. Summary 
 
N-ethylpentylone is shown to be detectable using cyclic voltammetry, in both PBS and 
acetate buffer over a range of pH’s and it was determined that pH 5.5 acetate buffer was 
the optimum medium for the electrochemical response. Both control samples and street 
samples were successfully detected in linear ranges of 25 – 600 µg mL-1 and 25 – 500 µg mL-
1  in acetate buffer (0.1 M, pH 5.5) respectively. The corresponding limit of detections in 
acetate buffer (0.1 M, pH 5.5) were calculated to be 0.046 µg mL-1 (control sample) and 
0.104 µg mL-1 (street sample). The technique of differential pulse voltammetry was also 
successfully utilized to detect the control sample and the linear range was found to be 25 – 
100 µg mL-1 with a limit of detection of 0.130 µg mL-1. In comparison, cyclic voltammetry 
was the preferred technique as there is a more linear relationship between peak height and 
concentration, and a lower LOD. The method of cyclic voltammetry was shown to be a 
selective method, as control samples were spiked with the three common adulterants, 
paracetamol, benzocaine and caffeine and were shown not to interfere with the expected 
electrochemical response of NEP. In regards to the electrochemical process, a scan rate 
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3.3. MDPHP Results  
 
3.3.1. Detection of MDPHP (control) in Acetate using Cyclic Voltammetry (CV) 
To determine the optimum conditions for the electrochemical detection of MDPHP, the 
electrochemical reduction response was investigated in acetate and phosphate buffer 
solution (PBS) over a range of pH’s and concentrations 
 
Figure 17. Cyclic voltammogram showing the electrochemical response of 500 µg 
mL-1 MDPHP in 0.1 M acetate buffer at pH 5.5 using screen-printed graphite 
macroelectrodes (vs. Ag/AgCl).  
 
The electrochemical response of 500 µg mL-1 MDPHP in 0.1 M acetate buffer was studied at 
pH 5.5 as shown in figure 17 as pH 5.5 was previously determined as the optimum condition 
during validation of the system. A scan was performed over the range 2 to -2 V which shows 
a visible oxidation peak at ≈ 0.64 V and a reduction peak at ≈ -1.4V. There is also a visible 
residual oxygen peak at -1 V although the solution was thoroughly degassed using nitrogen. 
The reduction peak has a greater peak intensity in comparison to the oxidation peak and is 
more defined in shape, therefore the region in which the reduction peak is visible will be 
focused on in future studies. As the chemical process is unknown, the process will be 
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3.3.2. pH study 
 
Figure 18 (A) Cyclic voltammograms showing the electrochemical response of 
5000 µg mL-1 MDPHP in 0.1 M acetate buffer at pH 4.3 (blue), 5.5 (orange), 9 
(grey) and 12 (yellow) using screen-printed graphite macroelectrodes (vs. 
Ag/AgCl). (B) Plot showing peak position vs pH  
















































49 | P a g e  
 
It was observed in figure 18 (A) that the MDPHP peak position shifts to a more negative 
potential as the pH is increased to a more basic medium, indicating the electrochemical 
reduction of NEP is a pH dependent process. The change in pH may affect the 
electrochemical reduction of MDPHP, resulting in a difference in peak position, as the 
concentration H+ and OH- ions are altered in the various pH solutions. The peak currents 
show that pH 5.5 is the optimum pH for the detection of the reduction peak, therefore an 
additions study was conducted using the optimum pH.  Fig 18 (B) shows a plot of peak 
position against pH, with a gradient of 29 mV, which is similar to the value of 33mV in 
literature by Smith et al36, indicating an electrochemical process involving double the 
number of electrons over that of protons.  
 
3.3.3. Additions Study 
The effect of the MDPHP concentration on peak current was studied in the optimum pH 5.5 
0.1 M acetate buffer, figure 19 (A) shows cyclic voltammograms produced and figure 19 (B) 






























Figure 19 (A) Cyclic voltammograms showing the electrochemical response of 1 – 
1000 µg mL-1 MDPHP in 0.1 M acetate buffer at pH 5.5 using screen-printed 
graphite macroelectrodes (vs. Ag/AgCl). (B) Overlay of calibration plots showing 
peak height vs concentration of MDPHP in 0.1 M acetate buffer at pH 4.3, 5.5, 9 
and 12. 
 
Figure 19 (A) shows the cyclic voltammograms produced at each concentration and displays 
that the higher concentrations yielded higher reduction peak intensities. At the highest 
concentration of 1000 µg mL-1 the peak shape is less defined in comparison to the peak 
produced at 500 µg mL-1 . An overlay of calibration plots showing peak current vs 
concentration in figure 19 (B) shows that as the pH increases to a more basic medium, the 






y = -7E-09x - 2E-06
R² = 1
y = -2E-08x - 6E-06
R² = 0.9671
y = -3E-08x + 2E-06
R² = 0.8563
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3.3.4. Scan Rate Study 
The effect of scan rate upon the electrochemical reduction of 500 μg mL-1 MDPHP in pH 5.5 
acetate buffer was investigated.   
 
Figure 20 (A). Calibration plot showing the relationship between Peak height and 
Square root of scan rate of 500 µg mL-1 MDPHP in 0.1 M acetate buffer at pH 5.5 
using screen-printed graphite macroelectrodes (vs. Ag/AgCl). (B) Calibration plot 
showing the relationship between Log (peak height) and Log (scan rate) of 500 µg 
mL-1 MDPHP in 0.1 M acetate buffer at pH 5.5 using screen-printed graphite 
macroelectrodes (vs. Ag/AgCl). 
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A plot of ‘peak height’ against the ‘square root of scan rate’ was found to be linear which 
indicates a diffusional process, as indicated with the following regression equation: Ip (A)= -
4.87 x 10-7 A – 8.51 x 10-6  A/(Vs-1)1/2 , R2= 0.802 (Figure 20 A). When plotting log peak height 
against log scan rate, a gradient close to 0.2 was found (Figure 20 B). It was expected that a 
gradient between 0.5 and 0.65 would be produced, indicating a diffusional process with 
some surface adsorption. However, as the value is lower than expected, further studies 
would have to be conducted to understand the process and ensure factors such as the 
electrode surface or model buffer solution were not affecting the results.  
 
3.3.5. Detection of MDPHP (Street Samples)  
The electrochemical responses of six different 500 µg mL-1 MDPHP street samples (referred 
to as “D15”, “D16”, “D19”, “T1D”, “T2C” and “T4B”) were studied in the optimum 0.1 M  
acetate buffer at pH 5.5 as determined in the initial experiment using the MDPHP control 
sample. A set concentration and pH were used in this part of the study as the aim was to 
determine whether the street samples contained MDPHP and could be electrochemically 
reduced.  
 
Figure 21. Cyclic voltammograms showing the electrochemical response of 500 
µg mL-1 MDPHP street samples (D15 (blue), D16 (orange), D19 (grey), T1D 
(yellow), T4B (dark blue) and T2C (green))  in 0.1 M acetate buffer at pH 5.5 using 
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Each street sample was studied over the range of 100 – 1000 µg mL-1 using cyclic 
voltammetry within the same potential window of 0 to -2 V as used in the control sample 
study. Figure 21 shows a summary of cyclic voltammograms produced by 500 µg of each 
street sample. The cyclic voltammograms shift to a more negative potential and increase in 
peak height as the concentration of street sample increased, which is attributed to a higher 
concentration of electroactive species in the solution that are available for reduction at the 
surface of the electrode. Table 3 shows the calculated Limit of Detection (LOD), Limit of 
Quantification (LOQ) and Relative Standard Deviation (RSD) of each street sample. D15 is 
shown to have the lowest LOD and LOQ. 
 












Deviation (RSD %) 
D15 0.130 0.433 2.92 
D16 0.201 0.671 2.88 
D19 0.192 0.641 2.47 
T1D 0.223 0.745 3.18 
T2C 0.272 0.907 4.57 
T4B 0.222 0.739 4.11 
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3.3.6. MDPHP Spiked Samples- Adulterants  
 
The selectivity of the method was tested in order to determine if commonly found 
adulterants in street samples affected the electrochemical response of MDPHP. Cyclic 
voltammograms of each street sample spiked with three common adulterants (paracetamol, 
caffeine and benzocaine) were recorded within the potential window previously used to 
detect the MDPHP control sample.   
 
 
Figure 22. Cyclic voltammograms showing the electrochemical response of 
MDPHP T2C spiked separately with 500µg of paracetamol (blue), caffeine (grey) 
and benzocaine (orange) in 0.1 M acetate buffer at pH 5.5 using screen-printed 
graphite macroelectrodes (vs. Ag/AgCl).  
The voltammograms of the MDPHP street sample (T2C) spiked with each adulterant are 
shown in figure 22: each adulterant shows a small oxidation peak at approximately -0.9 V, 
which indicates that there will be little interference with the electrochemical response of 
the reduction peak of MDPHP. The expected reduction peak of MDPHP is visible and the 
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3.3.7. Detection of MDPHP (Control) in Acetate using DPV 
 
The electrochemical reduction of 25 – 500 µg mL-1 N-ethylpentylone (control) in 0.1 M 
acetate buffer pH 5.5 was studied using differential pulse voltammetry in attempt to 
improve sensitivity as performed by Elbardisy et al in 201938 . Conditions were firstly 
optimised and the optimum conditions were found to be: modulation amplitude: 0.15 V; 
modulation time 0.15 s; interval time: 0.2 s; step: -0.005 V and scan rate: 0.025 V/s.  
 
Figure 23 (A) Differential pulse voltammograms showing the electrochemical 
response of MDPHP in 0.1 M acetate buffer at pH 5.5 using screen-printed 
graphite macroelectrodes (vs. Ag/AgCl). (B) Linear calibration plot of peak height 
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The electrochemical response shows a reduction peak at a similar potential to where 
MDPHP was detected in the cyclic voltammograms. As the concentration of MDPHP is 
increased the peak intensity increases and the peak shape becomes more defined. Plotting 
the peak height (Ip/ uA) against concentration (µg mL-1), in the range of 100 – 1000 µg mL-1, 
generated a linear plot providing an R2 value of 0.9027. The Limit of Detection was 
calculated to be 0.348 µg mL-1 and the RSD is 5.66%. As expected, the differential pulse 
voltammograms in figure 23 (A) show sharper and more well-resolved peaks than in 
comparison to the cyclic voltammograms in figure 19 (A).  
 
3.3.8. Detection of MDPHP (control) in a Biological Sample (Diluted Human Urine) 
To ascertain the relevance of the method investigated to the real life testing of biological 
samples, the electrochemical voltammetric response of MDPHP was tested in a sample of 
diluted human urine using cyclic voltammetry. The urine sample was diluted with pH 5.5 
acetate buffer and spiked with MDPHP over the range of 100 – 1000 µg mL-1 and a 
calibration curve was constructed.  
 
Figure 24 (A) Cyclic voltammograms showing the electrochemical response of 
MDPHP in human urine diluted with 0.1 M acetate buffer at pH 5.5 using screen-
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As shown in figure 24 (A), as the concentration of MDPHP increases, the peak potential 
shifts towards a more negative potential and the peak intensity increases, which is due to 
the increase in electroactive species at the electrode surface. The blank urine solution does 
not contain electroactive species that will interfere with the reduction of MDPHP as the 
voltammogram shows a small oxidation peak, due to other species that may be in the urine 
sample, but does not affect the electrochemical response of MDPHP.  
Plotting the peak height (Ip/µA) against concentration (µg mL-1) resulted in a linear plot, 
which is shown in figure 24 (B). Figure 24 (B) also displays the calibration curve constructed 
previously of MDPHP in acetate solution, 
 
Figure 24 (B) Overlay of calibration plots showing peak height vs concentration of 
MDPHP (control) in acetate solution pH 5.5 and diluted human urine  
The LOD corresponds to 0.205 µg mL -1 which is similar to the LOD found for MDPHP in the 
acetate buffer of 0.195 µg mL -1 . 
 
 
y = -2E-08x - 6E-06
R² = 0.9671
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3.3.9. Lowest Detection of MDPHP in a Biological Sample (Diluted Human Urine) 
 
As the method proved successful and relevant in the detection of MDPHP in a biological 
sample of diluted human urine, the method was tested to determine the lowest 
concentration of MDPHP detectable using cyclic voltammetry. Figure 25 shows the cyclic 
voltammograms recorded over the range of 0 (blank) to 6 µg mL-1.  
 
Figure 25. Cyclic voltammograms showing the electrochemical response of 0 – 6 
µg mL-1 MDPHP in human urine diluted with 0.1 M acetate buffer at pH 5.5 using 
screen-printed graphite macroelectrodes (vs. Ag/AgCl). 
 
Between 0 to 3 µg mL-1 there is no electrochemical response as there is no peak detected at 
the expected potential, the first electrochemical response is detected at 4µg mL-1 as there is 
a fluctuation at the expected potential and the peak becomes more apparent in the 
remaining higher concentrations. Therefore, the detection of MDPHP in a biological sample 
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3.3.10. Quantification of MDPHP in Street Samples 
 
The percentage quantification of MDPHP in each street sample was studied using cyclic 
voltammetry and compared to data acquired from the technique of gas chromatography-
mass spectrometry (GC-MS). A linear calibration plot was constructed using the control 
MDPHP in the range of 2000 – 2600 µg mL-1 with an R2 value of 0.9995. Peak heights of the 
six MDPHP street samples were recorded at the concentration 0f 2500 µg mL-1, the accurate 
mass of the samples weighed out were recorded in order to plot the data accurately. The 
average peak height of each street sample was recorded against the accurate concentration 
of each respective sample and this data was overlaid on the previously constructed MDPHP 
control calibration graph. Equation 3 was used to calculate the percentage quantification of 
MDPHP in each street sample. 
 
% 𝑄𝑢𝑎𝑛𝑡𝑖𝑓𝑖𝑐𝑎𝑡𝑖𝑜𝑛 = (
𝑃𝑒𝑎𝑘 ℎ𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑆𝑡𝑟𝑒𝑒𝑡 𝑆𝑎𝑚𝑝𝑙𝑒
𝑃𝑒𝑎𝑘 ℎ𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝐶𝑜𝑛𝑡𝑟𝑜𝑙 𝑆𝑎𝑚𝑝𝑙𝑒
) × 100 
Equation 3. Used to calculate percentage quantification of MDPHP in each street 
sample 
 
Results from the electrochemical method of cyclic voltammetry and gas chromatography-
mass spectrometry are compared in table 4: the results between the two techniques are 
found to be concurrent apart from one street sample, D19, which shows a 9.3 % difference 
in both results. The electrochemical technique shows a significantly lower percentage at 
51.2 % compared to the 60.5 % produced by GC-MS. Infrared spectroscopy (IR) was used to 
test the sample in question, which did not indicate the presence of any inorganic cutting 
agents that may have affected the result. The underestimation in quantification using the 
electrochemical technique may be due to surface adsorption on the electrode: the analyte 
may be sticking to the surface and preventing the diffusion process from occurring within 
the timescale of the measurement.  
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Table 4. MDPHP street sample quantification data comparison between GC-MS 




MDPHP is shown to be detectable using cyclic voltammetry, in acetate buffer over a range 
of pH’s and it was determined that pH 5.5 acetate buffer was the optimum medium for the 
electrochemical response. Both control samples and street samples were successfully 
detected in linear ranges of 100 – 1000 µg mL-1 in acetate buffer (0.1 M, pH 5.5). The 
corresponding limit of detections in acetate buffer (0.1 M, pH 5.5) were calculated to be 
0.195 µg mL-1 (control sample) and  0.130 µg mL-1  (street sample). The technique of 
differential pulse voltammetry was also successfully utilized to detect the control sample 
and the linear range was found to be 100 – 1000 µg mL-1 with a limit of detection of 0.348 
µg mL-1. In comparison, cyclic voltammetry was the preferred technique as there is a more 
linear relationship between peak height and concentration, and a lower LOD. The preferred 
technique successfully detected MDPHP in diluted human urine with a limit of detection of 
0.205 µg mL-1 and a lowest possible detection of 4µg mL-1. The method of cyclic 
voltammetry was also shown to be a selective method, as control samples were spiked with 
the three common adulterants, paracetamol, benzocaine and caffeine and were shown not 
Street Sample GC-MS Quantification (%) Electrochemistry 
Quantification (%) 
D15 91.7 91.9 
D16 79.0 81.8 
D19 60.5 51.2 
T1D 82.7 83.4 
T2C 81.0 81.1 
T4B 67.8 68.1 
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to interfere with the expected electrochemical response of MDPHP. The quantification of 
MDPHP in street samples was studied by comparing data using two different techniques of 
cyclic voltammetry and gas chromatography-mass spectrometry (GC-MS): the results are 
found to be concurrent apart from one result as the electrochemical technique shows a 
lower percentage. This may be due to surface adsorption on the electrode as infrared 
spectroscopy (IR) was used to test the sample in question, and did not indicate the presence 
of any inorganic cutting agents.  
In regards to the electrochemical process, a scan rate study was conducted, which produced 
a gradient value of 0.2, which was lower than the expected value and requires further work 





















62 | P a g e  
 
4. Conclusion  
 
For the first time, the electrochemical detection of both N-ethylpentylone and MDPHP, 
were found to be possible using the electrochemical techniques of cyclic voltammetry and 
differential pulse voltammetry in both model buffer solutions and biological samples. The 
use of cyclic voltammetry offered a limit of detection of 0.046 µg mL-1 and 0.195 µg mL-1 for 
NEP and MDPHP control samples in a model buffer solution. Whereas differential pulse 
voltammetry offered a limit of detection of 0.130 µg mL-1 and 0.348 µg mL-1 for NEP and 
MDPHP control samples in a model buffer solution. MDPHP was successfully detected using 
cyclic voltammetry in a biological sample of diluted human urine with a limit of detection of 
0.205 µg mL-1 and the method was proven to be selective as common adulterants did not 
interfere with the response of either NEP or MDPHP.  These results are significant for the 
development of an in-field portable sensor as the techniques used prove to be reliable, 
rapid and simple. The disposable nature of the screen-printed electrodes is a great solution 
to the issue that previous literature focused primarily on laboratory-based techniques that 
cannot be used in-field. Electrochemical techniques were proven to be successful in this 
thesis and can be used to address the current issue that frontline workers such a healthcare 
and police staff do not have a quick and easy technique to determine if NEP or MDPHP is 
present in the system. The primary aims of this thesis were successfully achieved and can be 
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5. Future Work 
 
Further studies into the chemical process may be undertaken in future to understand the 
electrochemical process in further detail, particularly in regards to MDPHP as the scan rate 
study did not produce the expected results. A more extensive scan rate study may be 
carried out to learn about the electrochemical process. The development of a portable 
sensor using the data collected is also a possibility.  
As NEP was detected successfully in the tested matrix, this can be used as the basis for 
future work in regards to the detection of NEP in a biological sample, if shown to be 
successful this will strongly support the development of an in-the-field portable sensor.  
MDPHP was successfully detected in a biological sample using cyclic voltammetry and 
further investigations to improve the sensitivity can be conducted by utilising differential 
pulse voltammetry. A comparison of the detection of MDPHP in both cyclic voltammetry 
and differential pulse voltammetry would be the next step in the development of an in-the-
















64 | P a g e  
 
6. References 
1. World Drug Report 2019 (United Nations publication, Sales No. E.19.XI.8). 
2. Drugs Misuse: Findings from the 2018/19 Crime Survey for England and Wales, 
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attac
hment_data/file/832533/drug-misuse-2019-hosb2119.pdf, (accessed 12/10/2019).  
3. UNODC, Early Warning Advisory on New Psychoactive Substances (What are NPS), 
2019. 
4. UNODC, Early Warning Advisory on New Psychoactive Substances (NPS Substance 
Groups), 2019. 
5. World Drug Report 2019 Stimulants (United Nations publication, Sales No. E.19.XI.8). 
6. UNODC, Early Warning Advisory on New Psychoactive Substances (Legal Responses), 
2019. 
7. Early Warning System on NPS, http://www.emcdda.europa.eu/publications/topic-
overviews/eu-early-warning-system_en, (accessed 13/10/2019) 
8. D. Trinklein, F. Zobel, E. Quigley, B. Hughes and R. Hochwieser, EMCDDA Papers Drug 
Policy Profile: Austria, Luxembourg: Publications Office of the European Union, 2014, 
DOI: 10.2810/48287 
9. Criminal Justice (Psychoactive Substances) Act 2010, 
http://www.irishstatutebook.ie/eli/2010/act/22/enacted/en/print, (accessed 
12/10/2019). 
10. Psychoactive Substances Act 2013, 
http://www.legislation.govt.nz/act/public/2013/0053/latest/whole.html#DLM50431
49, (accessed 15/10/2019).  
11. Psychoactive Substances Act 2016, 
http://www.legislation.gov.uk/ukpga/2016/2/crossheading/offences/enacted, 
(accessed 13/10/2019). 
12. Kelly, J. P. 2011. Cathinone derivatives: A review of their chemistry, pharmacology 
and toxicology. Drug Testing and Analysis 3 :439–53. doi:10.1002/dta.313 
13. Sanchez, S., 1929. Sur un homologue de l’ephedrine. Bull. Soc. Chim. Fr. 45, 284–286. 
14. Jerrold S. Meyer and Linda F. Quenzer, Psychopharmacology: Drugs, the Brain, and 
the Behavior, 3rd ed. (Oxford, Oxford University Press, 2019). 
15. Bath Salts Drug, https://www.drugs.com/illicit/bath-salts.html, (accessed 
12/10/2019). 
16. Prosser, J.M. & Nelson, L.S. J. Med. Toxicol. (2012) 8: 33. 
https://doi.org/10.1007/s13181-011-0193-z 
17. Atherton, D. , Dye, D. , Robinson, C. A. and Beck, R. (2019), n‐Ethyl Pentylone‐Related 
Deaths in Alabama. J Forensic Sci, 64: 304-308. doi:10.1111/1556-4029.13823 
18. Ikeji, Chisom & Sittambalam, Charmian & Camire, Lyn & Weisman, David. (2018). 
Fatal intoxication with N-ethylpentylone: a case report. Journal of Community 
Hospital Internal Medicine Perspectives. 8. 307-310. DOI: 
10.1080/20009666.2018.1510711. 
65 | P a g e  
 
19. Usher, T. , New batch of MDMA and ecstasy pills being made with potentially lethal 
chemical, https://metro.co.uk/2018/08/15/new-batch-of-mdma-and-ecstasy-pills-
being-made-with-potentially-lethal-chemical-7842842/, (accessed 09/10/2019). 
20. Desharnais et al (2017). A case of fatal idiosyncratic reaction to the designer drug 
3,4-methylenedioxypyrovalerone (MDPV) and review of the literature. Forensic 
science, medicine, and pathology. 13. 10.1007/s12024-017-9894-1. 
21. European Monitoring Centre for Drugs and Drug Addiction (2014), Report on the risk 
assessment of 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one (3,4-
methylenedioxypyrovalerone, MDPV) in the framework of the Council Decision on 
new psychoactive substances, Risk Assessments, Publications Office of the European 
Union, Luxembourg.  
22. Burnett, T. , https://www.stokesentinel.co.uk/news/stoke-on-trent-news/monkey-
dust-police-stoke-staffordshire-1882861, (accessed 15/10/2019) 
23. https://www.bbc.co.uk/news/uk-england-stoke-staffordshire-45144531, (accessed 
15/10/2019) 
24. Błażewicz, A., Bednarek, E., Popławska, M. et al. Forensic Toxicol (2019) 37: 288. 
https://doi.org/10.1007/s11419-018-00463-w 
25. Wei-Yin Hong, Ya-Chun Ko, Mei-Chih Lin, Po-Yu Wang, Yu-Pen Chen, Lih-Ching 
Chiueh, Daniel Yang-Chih Shih, Hsiu-Kuan Chou, Hwei-Fang Cheng, Determination of 
Synthetic Cathinones in Urine Using Gas Chromatography–Mass Spectrometry 
Techniques, Journal of Analytical Toxicology, Volume 40, Issue 1, January/February 
2016, Pages 12–16, https://doi.org/10.1093/jat/bkv108 
26. Levitas, M.P., Andrews, E., Lurie, I., Marginean, I., Discrimination of synthetic 
cathinones by GC–MS and GC–MS/MS using cold electron ionization, Forensic 
Science International, Volume 288 https://doi.org/10.1016/j.forsciint.2018.04.026 
27. Mabbott, S., Eckmann, A., Casiraghi, C. and Goodacre, R., Analyst, 2013 
28. LaPointe, J., Musselman, B., O’Neill, T. et al. J. Am. Soc. Mass Spectrom., 2015, 26: 
159. 
29.  Srinivasan S. (2006) ELECTRODE/ELECTROLYTE INTERFACES: STRUCTURE AND 
KINETICS OF CHARGE TRANSFER. In: Fuel Cells. Springer, Boston, MA 
30. Autolab Application Note EC08, 
https://www.ecochemie.nl/download/Applicationnotes/Autolab_Application_Note_EC08.pd
f, (accessed 20/10/2019). 
31. O. D. Renedo, M. A. Alonso-Lomillo and M. J. A. Martinez, Talanta, 2007, 73, 202–219 
32. C. Karuwan , A. Wisitsoraat , D. Phokharatkul , C. Sriprachuabwong , T. Lomas , D. 
Nacaprichab and A. Tuantranont , RSC Adv., 2013, 3 , 25792 —2579 
33. Y. V. R. R. V. Krishnaiah, V. Hanuman Reddy, M. ThirupaluReddy and G. 
MadhuSudana Rao, Int. J. Sci. Res., 2012, 1,14–17 
34. Mercury and health, https://www.who.int/news-room/fact-sheets/detail/mercury-
and-health, (accessed 24/10/2019). 
35. Smith, J.,Metters, J.P., Irving, C., Sutcliffe, O.B. and Banks, C.B., Analyst, 2014, 139, 
389 
36.  Smith, J.,Metters, J., Khreit, O.,Sutcliffe, O. and Banks, C. Analytical Chemistry, 2014, 
86, 9985-9992. 
66 | P a g e  
 
37. Tsujikawa, K., Mikuma, T., Kuwayama, K., Miyaguchi, H., Kanamori, T., Iwata, Y.T., et 
al. . (2012) Degradation pathways of 4-methylmethcathinone in alkaline solution and 
stability of methcathinone analogs in various pH solutions. Forensic Science 
International, 220, 103–110. 
38. H. M. Elbardisy, A. G. Ferrari, C. W. Foster, O. B. Sutcliffe, D. A. Brownson, T. S. Belal, 
W. Talaat, H. G. Daabess and C. E. Banks, ACS Omega, 2019, 4, 1947-1954 
 
